Showing results (171-180 of 279) with videos related to
Sort By:
Pageof 28
Annals of the Rheumatic Diseases|October 1, 1977
Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroupsD M Grennan, C Bunn, G R Hughes, et al.British Journal of Clinical Pharmacology|May 1, 1978
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacyP J Rooney, H A Capell, S Paterson, et al.Clinical and Experimental Immunology|February 1, 1983
Complement-mediated inhibition of immune precipitation in patients with immune complex diseasesJ K Naama, W S Mitchell, A Zoma, et al.Clinical and Experimental Immunology|January 1, 1986
Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosusE Holme, A Fyfe, A Zoma, et al.FEBS Letters|August 4, 1997
Role of the distal hinge region of C1-inhibitor in the regulation of C1s activityS He, J C Yang, S Tsang, et al.The British Journal of Ophthalmology|January 1, 1975
Studies of the viral flora in keratoconjunctivitis siccaJ Willamson, W M Doig, J V Forrester, et al.Scandinavian Journal of Rheumatology|January 1, 1984
Inhibition of immune precipitation in rheumatic disease. A clinical and laboratory studyJ K Naama, W S Mitchell, D Lewis, et al.Human Genetics|April 1, 1990
Regional assignment of the human C1-inhibitor gene to 11q11-q13.1A Theriault, K Whaley, A R McPhaden, et al.Rheumatology International|January 1, 1992
The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherenceE R Holme, J Veitch, A Johnston, et al.Clinical and Experimental Immunology|November 1, 1984
Prevention of immune precipitation by purified classical pathway complement componentsJ K Naama, A O Hamilton, A C Yeung-Laiwah, et al.Pageof 28